Hans de Haan

<p>First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy</p>

Pamela N. Münster, Monica Mita, Amit Mahipal et al. · Cancer Management and Research · 2019 · 81 citations · Full text

Phase I Trial of Intravenous IL-4 Pseudomonas Exotoxin Protein (NBI-3001) in Patients with Advanced Solid Tumors That Express the IL-4 Receptor

Linda L. Garland, Barbara J. Gitlitz, Scot Ebbinghaus et al. · Journal of Immunotherapy · 2005 · 49 citations

Metabolically assessed muscle fibre recruitment in brief isometric contractions at different intensities

J. G. M. Beltman, A. de Haan, Hans de Haan et al. · European Journal of Applied Physiology · 2004 · 31 citations

Muscle Function, Kinesiology, Physiological Research +8

Discovering the sky at the Longest Wavelengths (DSL)

Albert‐Jan Boonstra, Michael Garrett, Gert Kruithof et al. · 2016 · 31 citations

Radar, Engineering, Satellite Instrumentation +14

A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms

Edward M. Wolin, Alain C. Mita, Amit Mahipal et al. · PLoS ONE · 2019 · 27 citations · Full text

Chemoprevention Strategy, Pathology, Pharmacotherapy +21